{
  "id": "guillain-barre-syndrome",
  "title": "Guillain-Barré Syndrome (GBS)",
  "version": "1.0",
  "icd10": [
    "** G61.0 (Guillain-Barré syndrome)"
  ],
  "scope": "** Acute inflammatory polyradiculoneuropathy including AIDP, AMAN, AMSAN, and Miller Fisher syndrome (MFS) variants. Covers acute diagnosis, respiratory monitoring, immunotherapy (IVIG/PLEX), autonomic dysfunction management, pain control, and rehabilitation planning. Excludes CIDP (chronic inflammatory demyelinating polyneuropathy — separate template), tick paralysis, and chronic neuropathies.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC with differential (CPT 85025)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Baseline; infection screen; exclude hematologic causes",
          "target": "Normal; leukocytosis suggests infection trigger"
        },
        {
          "item": "CMP (BMP + LFTs) (CPT 80053)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Electrolyte abnormalities (hyponatremia from SIADH), renal/hepatic function for IVIG dosing",
          "target": "Normal"
        },
        {
          "item": "Magnesium (CPT 83735)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Hypomagnesemia worsens weakness; arrhythmia risk",
          "target": ">1.8 mg/dL"
        },
        {
          "item": "Phosphorus (CPT 84100)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Hypophosphatemia causes weakness (mimic)",
          "target": ">2.5 mg/dL"
        },
        {
          "item": "ESR (CPT 85652) / CRP (CPT 86140)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "rationale": "Inflammatory markers; infection screen",
          "target": "Mildly elevated (non-specific)"
        },
        {
          "item": "Blood glucose (CPT 82947)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Diabetes as comorbidity; hyperglycemia management",
          "target": "Normal"
        },
        {
          "item": "Urinalysis (CPT 81003)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "UTI as precipitant; baseline",
          "target": "Normal"
        },
        {
          "item": "Pregnancy test (β-hCG)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "STAT",
          "rationale": "Affects IVIG formulation choice; imaging considerations",
          "target": "Document result"
        },
        {
          "item": "PT/INR (CPT 85610), aPTT (CPT 85730)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Coagulation status before procedures (LP, central line)",
          "target": "Normal"
        },
        {
          "item": "Type and screen (CPT 86900)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "STAT",
          "rationale": "Potential need for PLEX",
          "target": "On file"
        }
      ],
      "Extended Workup (Second-line)": [
        {
          "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b) (CPT 86255)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE",
          "rationale": "GM1: AMAN; GQ1b: Miller Fisher; GD1a: AMAN; helps confirm diagnosis and subtype",
          "target": "Positive supports diagnosis (negative does not exclude)"
        },
        {
          "item": "Anti-GQ1b antibody",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Miller Fisher syndrome (ataxia, ophthalmoplegia, areflexia)",
          "target": "Positive in >90% MFS"
        },
        {
          "item": "Campylobacter jejuni serology (IgM, IgG)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Most common infectious trigger (30%); AMAN variant association",
          "target": "Positive IgM suggests recent infection"
        },
        {
          "item": "Mycoplasma pneumoniae IgM",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Common triggering infection",
          "target": "Positive IgM suggests recent infection"
        },
        {
          "item": "CMV IgM",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Triggering infection; associated with severe demyelinating GBS",
          "target": "Positive IgM"
        },
        {
          "item": "EBV panel (VCA IgM, EBNA)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Triggering infection",
          "target": "Positive VCA IgM"
        },
        {
          "item": "Hepatitis B surface antigen, anti-HBc (CPT 80074)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Screen before IVIG; reactivation risk",
          "target": "Negative"
        },
        {
          "item": "Hepatitis C antibody (CPT 80074)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Cryoglobulinemia-associated neuropathy (differential)",
          "target": "Negative"
        },
        {
          "item": "HIV 1/2 antigen/antibody (CPT 87389)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "HIV-associated neuropathy; acute HIV can mimic GBS",
          "target": "Negative"
        },
        {
          "item": "TSH (CPT 84443)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Thyroid dysfunction can cause weakness",
          "target": "Normal"
        },
        {
          "item": "B12 (CPT 82607), methylmalonic acid (CPT 83921)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "B12 deficiency neuropathy (differential)",
          "target": "Normal"
        },
        {
          "item": "Serum protein electrophoresis (SPEP) with immunofixation (CPT 86334)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Paraproteinemia-associated neuropathy (differential); POEMS",
          "target": "Normal"
        },
        {
          "item": "IgA level (quantitative)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "ROUTINE",
          "rationale": "IgA deficiency contraindicates standard IVIG (anaphylaxis risk); check BEFORE IVIG if possible",
          "target": "Normal (>7 mg/dL)"
        }
      ],
      "Rare/Specialized (Refractory or Atypical)": [
        {
          "item": "Zika virus serology/PCR",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Endemic areas; associated with GBS outbreaks",
          "target": "Negative"
        },
        {
          "item": "Influenza A/B PCR",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "-",
          "ICU": "EXT",
          "rationale": "Triggering infection; seasonal",
          "target": "Negative"
        },
        {
          "item": "COVID-19 PCR/antigen",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "ROUTINE",
          "rationale": "Post-COVID GBS association reported",
          "target": "Document result"
        },
        {
          "item": "Lyme serology (ELISA, Western blot)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Lyme-associated polyradiculopathy (differential); endemic areas",
          "target": "Negative"
        },
        {
          "item": "Paraneoplastic panel (serum) (CPT 86255)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If atypical features or poor response to treatment",
          "target": "Negative"
        },
        {
          "item": "Heavy metals (lead, arsenic, thallium)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Toxic neuropathy mimic; occupational exposure",
          "target": "Normal"
        },
        {
          "item": "Porphyrins (urine ALA, PBG)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Acute intermittent porphyria mimic (motor predominant, autonomic dysfunction)",
          "target": "Normal"
        },
        {
          "item": "Anti-MAG antibody (CPT 86255)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "MAG-associated neuropathy (differential; chronic presentation)",
          "target": "Negative"
        }
      ],
      "Lumbar Puncture": [
        {
          "item": "Opening pressure",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Rule out elevated ICP",
          "target": "10-20 cm H2O (normal)"
        },
        {
          "item": "Cell count (tubes 1 and 4) (CPT 89051)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Albuminocytologic dissociation",
          "target": "WBC <10 cells/µL (if >50 WBC, reconsider diagnosis — HIV, Lyme, sarcoidosis, lymphoma)"
        },
        {
          "item": "Protein (CPT 84157)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Classic finding: elevated protein with normal WBC",
          "target": "Elevated >45 mg/dL (often >100 mg/dL; may be normal in first week)"
        },
        {
          "item": "Glucose with serum glucose (CPT 82945)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Normal in GBS; low in infectious/malignant meningitis",
          "target": "Normal (>60% serum)"
        },
        {
          "item": "Gram stain and culture",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Exclude bacterial meningitis",
          "target": "No organisms"
        },
        {
          "item": "Cytology (CPT 88104)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Exclude leptomeningeal lymphoma/carcinomatosis",
          "target": "Negative"
        },
        {
          "item": "VDRL (CSF) (CPT 86592)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Neurosyphilis can mimic",
          "target": "Negative"
        },
        {
          "item": "Oligoclonal bands (CPT 83916), IgG index",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "rationale": "Differentiate from MS; may be positive in GBS (non-specific)",
          "target": "Negative or low titer"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "MRI spine with and without contrast (whole spine) (CPT 72156)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "Within 24h of presentation",
          "target": "Nerve root enhancement (anterior roots in AIDP); exclude compressive myelopathy, spinal cord lesion, epidural abscess",
          "contraindications": "Pacemaker, metallic implants"
        },
        {
          "item": "Nerve conduction studies (CPT 95907-95913) / EMG (CPT 95886) (NCS/EMG)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "timing": "Ideally within 3-5 days of symptom onset (may be normal in first 48h); repeat at 2-3 weeks if initially non-diagnostic",
          "target": "Demyelinating pattern: prolonged distal latencies, conduction block, temporal dispersion, prolonged F-waves, absent H-reflex. Axonal pattern (AMAN): reduced CMAP amplitudes with normal velocities",
          "contraindications": "None significant; avoid anticoagulated patients for EMG needle exam"
        },
        {
          "item": "Chest X-ray (CPT 71046)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "URGENT",
          "timing": "On admission",
          "target": "Aspiration, atelectasis, baseline for ventilator management",
          "contraindications": "None significant"
        },
        {
          "item": "ECG (12-lead) (CPT 93000)",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "URGENT",
          "timing": "On admission and PRN",
          "target": "Arrhythmias (sinus tachycardia, bradycardia, AV block); autonomic dysfunction",
          "contraindications": "None"
        }
      ],
      "Extended": [
        {
          "item": "MRI brain with and without contrast (CPT 70553)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE",
          "timing": "If Miller Fisher variant suspected or cranial nerve involvement",
          "target": "Cranial nerve enhancement (especially CN III, VI, VII); exclude central lesion",
          "contraindications": "Same as MRI"
        },
        {
          "item": "CT chest with contrast (CPT 71260)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "If paraneoplastic etiology suspected; thymoma screen if MG in differential",
          "target": "Mass lesion",
          "contraindications": "Contrast allergy, renal impairment"
        },
        {
          "item": "Repeat NCS/EMG",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "At 2-4 weeks if initial study non-diagnostic or to assess prognosis",
          "target": "Evolution of findings; axonal degeneration predicts slower recovery",
          "contraindications": "Same as initial"
        },
        {
          "item": "Echocardiogram (CPT 93306)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "ROUTINE",
          "timing": "If autonomic instability or new murmur",
          "target": "Cardiac function; Takotsubo in severe autonomic GBS",
          "contraindications": "None significant"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Nerve ultrasound (high-resolution)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "If diagnosis uncertain",
          "target": "Nerve enlargement in CIDP (helps differentiate); some enlargement reported in GBS",
          "contraindications": "None"
        },
        {
          "item": "Pulmonary function testing (formal) (CPT 94010)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If borderline respiratory function",
          "target": "Full spirometry for outpatient monitoring",
          "contraindications": "Unable to cooperate"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent": [
        {
          "item": "IVIG (intravenous immunoglobulin) (CPT 96365)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg",
                "orderSentence": "IVIG (intravenous immunoglobulin) (CPT 96365) 0.4 g/kg IV"
              }
            ],
            "route": "IV",
            "instructions": "0.4 g/kg/day IV x 5 days (total 2 g/kg); infuse over 4-8h per dose; slow initial rate and increase per protocol. Start within 2 weeks of symptom onset for maximum benefit",
            "orderSentence": "IVIG (intravenous immunoglobulin) (CPT 96365) 0.4 g/kg IV"
          },
          "contraindications": "IgA deficiency (use IgA-depleted product); acute renal failure; anaphylaxis to immunoglobulin",
          "monitoring": "Vital signs q15min during first infusion, then q30min; renal function (BUN, Cr) before and during; headache (aseptic meningitis); thrombotic events; hemolysis (haptoglobin, LDH, direct Coombs if symptoms)",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Plasmapheresis (PLEX) (CPT 36514)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "instructions": "5 exchanges over 7-14 days (typically every other day); each exchange 1-1.5 plasma volumes; use albumin replacement. Start within 4 weeks of symptom onset",
            "orderSentence": "Plasmapheresis (PLEX) (CPT 36514) - - - see dosing"
          },
          "contraindications": "Hemodynamic instability, severe sepsis, active bleeding, heparin allergy (for circuit anticoagulation), poor vascular access",
          "monitoring": "BP and HR continuous during exchange; calcium (citrate toxicity: tingling, cramping); fibrinogen; CBC; electrolytes; line site infection",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "Intubation and mechanical ventilation",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mL/kg",
                "orderSentence": "Intubation and mechanical ventilation 20 mL/kg -"
              }
            ],
            "route": "-",
            "instructions": "Indications (20/30/40 rule): FVC <20 mL/kg, NIF weaker than -30 cmH2O, >30% decline in FVC from baseline, or clinical respiratory distress. Use non-depolarizing agents (avoid succinylcholine — hyperkalemia risk). RSI with rocuronium preferred",
            "orderSentence": "Intubation and mechanical ventilation 20 mL/kg -"
          },
          "contraindications": "N/A (life-saving)",
          "monitoring": "Ventilator settings per ICU protocol; sedation; daily spontaneous breathing trial when improving",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        },
        {
          "item": "DVT prophylaxis: Enoxaparin",
          "route": "SC",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "40 mg",
                "orderSentence": "DVT prophylaxis: Enoxaparin 40 mg SC"
              }
            ],
            "route": "SC",
            "instructions": "40 mg SC daily; start on admission",
            "orderSentence": "DVT prophylaxis: Enoxaparin 40 mg SC"
          },
          "contraindications": "Active bleeding, platelets <50K, CrCl <30 (use UFH)",
          "monitoring": "Platelets q3 days; anti-Xa if renal impairment",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "ROUTINE"
        },
        {
          "item": "DVT prophylaxis: Heparin SC (alternative)",
          "route": "SC",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "5000 units",
                "orderSentence": "DVT prophylaxis: Heparin SC (alternative) 5000 units SC"
              }
            ],
            "route": "SC",
            "instructions": "5000 units SC q8-12h",
            "orderSentence": "DVT prophylaxis: Heparin SC (alternative) 5000 units SC"
          },
          "contraindications": "Active bleeding, HIT",
          "monitoring": "Platelets q3 days",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "ROUTINE"
        },
        {
          "item": "Pneumatic compression devices",
          "route": "-",
          "indication": "-",
          "dosing": {
            "instructions": "Apply bilaterally on admission; continue until ambulatory",
            "orderSentence": "Pneumatic compression devices - - - see dosing"
          },
          "contraindications": "Acute DVT, severe PVD",
          "monitoring": "Skin checks daily",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT"
        }
      ],
      "Symptomatic Treatments": [
        {
          "item": "Gabapentin",
          "route": "PO",
          "indication": "Neuropathic pain (very common in GBS — 55-89%)",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg",
                "orderSentence": "Gabapentin 300 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 300 mg PO qHS; increase by 300 mg/day every 1-3 days; target 900-1800 mg TID; max 3600 mg/day",
            "orderSentence": "Gabapentin 300 mg PO"
          },
          "contraindications": "Severe renal impairment (dose adjust); oversedation",
          "monitoring": "Sedation, dizziness; adjust for renal function",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Pregabalin",
          "route": "PO",
          "indication": "Neuropathic pain (alternative)",
          "dosing": {
            "doseOptions": [
              {
                "text": "75 mg",
                "orderSentence": "Pregabalin 75 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 75 mg PO BID; increase to 150 mg BID after 3-7 days; max 300 mg BID",
            "orderSentence": "Pregabalin 75 mg PO"
          },
          "contraindications": "Renal impairment (dose adjust)",
          "monitoring": "Sedation, weight gain, peripheral edema",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Carbamazepine",
          "route": "PO",
          "indication": "Neuropathic pain (alternative)",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg",
                "orderSentence": "Carbamazepine 100 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 100 mg PO BID; increase by 100 mg/day q3-7 days; target 400-800 mg/day in divided doses; max 1200 mg/day",
            "orderSentence": "Carbamazepine 100 mg PO"
          },
          "contraindications": "AV block, bone marrow suppression, HLA-B*1502 (Asian descent — screen before starting)",
          "monitoring": "CBC, LFTs, sodium at baseline and 2-4 weeks; drug level",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Amitriptyline",
          "route": "PO",
          "indication": "Neuropathic pain, insomnia",
          "dosing": {
            "doseOptions": [
              {
                "text": "10-25 mg",
                "orderSentence": "Amitriptyline 10-25 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 10-25 mg PO qHS; increase by 10-25 mg q1-2 weeks; max 150 mg/day",
            "orderSentence": "Amitriptyline 10-25 mg PO"
          },
          "contraindications": "Arrhythmia, urinary retention, angle-closure glaucoma, recent MI",
          "monitoring": "ECG if cardiac risk; anticholinergic side effects",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Acetaminophen",
          "route": "PO",
          "indication": "Musculoskeletal pain, headache",
          "dosing": {
            "doseOptions": [
              {
                "text": "650-1000 mg",
                "orderSentence": "Acetaminophen 650-1000 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "650-1000 mg PO q6h; max 4g/day (2g hepatic impairment)",
            "orderSentence": "Acetaminophen 650-1000 mg PO"
          },
          "contraindications": "Severe liver disease",
          "monitoring": "LFTs if prolonged",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "STAT"
        },
        {
          "item": "Morphine IV",
          "route": "IV",
          "indication": "Severe pain unresponsive to above",
          "dosing": {
            "doseOptions": [
              {
                "text": "2-4 mg",
                "orderSentence": "Morphine IV 2-4 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "2-4 mg IV q3-4h PRN; use with caution — respiratory depression risk especially with respiratory compromise",
            "orderSentence": "Morphine IV 2-4 mg IV"
          },
          "contraindications": "Respiratory failure (relative — monitor closely), ileus",
          "monitoring": "RR, SpO2, sedation scale; bowel function",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT"
        },
        {
          "item": "Oxycodone",
          "route": "PO",
          "indication": "Moderate-severe pain (if able to swallow)",
          "dosing": {
            "doseOptions": [
              {
                "text": "5-10 mg",
                "orderSentence": "Oxycodone 5-10 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "5-10 mg PO q4-6h PRN",
            "orderSentence": "Oxycodone 5-10 mg PO"
          },
          "contraindications": "Same as morphine",
          "monitoring": "Same as morphine",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Metoclopramide",
          "route": "IV",
          "indication": "Gastroparesis, nausea (autonomic dysfunction)",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg",
                "orderSentence": "Metoclopramide 10 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "10 mg IV/PO q6h PRN; max 40 mg/day; limit duration to <12 weeks",
            "orderSentence": "Metoclopramide 10 mg IV"
          },
          "contraindications": "Seizure history, Parkinson disease, GI obstruction",
          "monitoring": "Tardive dyskinesia with prolonged use",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "ROUTINE"
        },
        {
          "item": "Docusate sodium",
          "route": "PO",
          "indication": "Constipation (immobility + opioids)",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg",
                "orderSentence": "Docusate sodium 100 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "100 mg PO BID",
            "orderSentence": "Docusate sodium 100 mg PO"
          },
          "contraindications": "GI obstruction",
          "monitoring": "Bowel function",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE"
        },
        {
          "item": "Senna",
          "route": "PO",
          "indication": "Constipation",
          "dosing": {
            "doseOptions": [
              {
                "text": "8.6-17.2 mg",
                "orderSentence": "Senna 8.6-17.2 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "8.6-17.2 mg PO qHS",
            "orderSentence": "Senna 8.6-17.2 mg PO"
          },
          "contraindications": "GI obstruction",
          "monitoring": "Bowel function",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Polyethylene glycol (MiraLAX)",
          "route": "PO",
          "indication": "Constipation (if docusate insufficient)",
          "dosing": {
            "doseOptions": [
              {
                "text": "17 g",
                "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
              }
            ],
            "route": "PO",
            "instructions": "17 g PO daily in 8 oz water",
            "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
          },
          "contraindications": "GI obstruction",
          "monitoring": "Bowel function",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Melatonin",
          "route": "PO",
          "indication": "Insomnia (ICU delirium prevention)",
          "dosing": {
            "doseOptions": [
              {
                "text": "3-5 mg",
                "orderSentence": "Melatonin 3-5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "3-5 mg PO qHS",
            "orderSentence": "Melatonin 3-5 mg PO"
          },
          "contraindications": "None significant",
          "monitoring": "Sleep quality",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "ROUTINE"
        },
        {
          "item": "Lorazepam",
          "route": "IV",
          "indication": "Anxiety, autonomic crisis",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5-1 mg",
                "orderSentence": "Lorazepam 0.5-1 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "0.5-1 mg IV/PO q6-8h PRN",
            "orderSentence": "Lorazepam 0.5-1 mg IV"
          },
          "contraindications": "Respiratory compromise (use with extreme caution)",
          "monitoring": "RR, sedation",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT"
        }
      ],
      "Second-line/Refractory": [
        {
          "item": "Second course IVIG",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg",
                "orderSentence": "Second course IVIG 0.4 g/kg PO"
              }
            ],
            "route": "PO",
            "instructions": "0.4 g/kg/day x 5 days; consider if progressive deterioration after initial treatment or treatment-related fluctuation (TRF)",
            "orderSentence": "Second course IVIG 0.4 g/kg PO"
          },
          "contraindications": "Same as initial IVIG",
          "monitoring": "Same as initial IVIG",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT"
        },
        {
          "item": "PLEX after IVIG failure",
          "route": "-",
          "indication": "-",
          "dosing": {
            "instructions": "5 exchanges over 7-14 days; wait ≥2 weeks after IVIG to avoid washing out immunoglobulin",
            "orderSentence": "PLEX after IVIG failure - - - see dosing"
          },
          "contraindications": "Same as initial PLEX",
          "monitoring": "Same as initial PLEX",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "URGENT"
        },
        {
          "item": "IV methylprednisolone (NOT standard of care) (CPT 96365)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg",
                "orderSentence": "IV methylprednisolone (NOT standard of care) (CPT 96365) 500 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "500 mg IV daily x 5 days; evidence does NOT support steroids alone; may be considered in combination with IVIG per some centers for refractory cases",
            "orderSentence": "IV methylprednisolone (NOT standard of care) (CPT 96365) 500 mg IV"
          },
          "contraindications": "Active infection, uncontrolled diabetes",
          "monitoring": "Glucose, BP, GI prophylaxis",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "-",
          "ICU": "EXT"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology consultation",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "indication": "All suspected GBS; diagnostic confirmation, treatment initiation"
        },
        {
          "item": "Pulmonology / Critical care",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "-",
          "ICU": "STAT",
          "indication": "Declining respiratory function; intubation decision; ventilator management"
        },
        {
          "item": "Physical therapy (PT)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "indication": "Early passive ROM to prevent contractures; gradual mobilization as tolerated; gait training"
        },
        {
          "item": "Occupational therapy (OT)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "indication": "Upper extremity function, ADLs, adaptive equipment"
        },
        {
          "item": "Speech-language pathology (SLP)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "URGENT",
          "indication": "Dysphagia evaluation (bulbar weakness); aspiration prevention"
        },
        {
          "item": "Rehabilitation medicine (physiatry)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Rehabilitation planning; disposition (inpatient rehab vs SNF)"
        },
        {
          "item": "Pain management",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "ROUTINE",
          "indication": "Refractory neuropathic pain"
        },
        {
          "item": "Social work",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Discharge planning, family support, financial resources"
        },
        {
          "item": "Psychology / Psychiatry",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Anxiety, depression, PTSD (common in ICU patients)"
        },
        {
          "item": "Respiratory therapy",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "STAT",
          "indication": "Bedside spirometry (FVC, NIF); pulmonary toilet; ventilator weaning"
        },
        {
          "item": "Nutrition / Dietitian",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "ROUTINE",
          "indication": "Enteral feeding plan if intubated; caloric needs during recovery"
        },
        {
          "item": "Infectious disease",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-",
          "indication": "If triggering infection unclear or atypical presentation"
        }
      ],
      "Patient Instructions": [
        {
          "item": "Return to ED / Call 911 if: increasing difficulty breathing, new swallowing difficulty, rapid worsening of weakness, inability to walk, chest pain, or lightheadedness",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE"
        },
        {
          "item": "GBS is typically a self-limited illness; most patients recover substantially but recovery may take months to years",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Do NOT drive until strength and reflexes have recovered and neurology clears",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Comply with physical therapy exercises as prescribed between sessions",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Pain is normal in GBS and will be managed with medications; report if pain is inadequately controlled",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Inform future healthcare providers about GBS history (vaccine considerations, anesthesia precautions)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Fall prevention: use assistive devices (walker, cane) as recommended; remove tripping hazards at home",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Monitor for signs of blood clots: leg swelling, redness, chest pain, shortness of breath",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Follow-up with neurology in 2-4 weeks after discharge; NCS/EMG may be repeated at 3-6 months",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Gradual return to activity as tolerated; avoid overexertion during recovery",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Balanced nutrition for nerve recovery (adequate protein, B vitamins)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Smoking cessation (impairs nerve healing)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Adequate sleep (promotes neurologic recovery)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Mental health support (depression and anxiety common during recovery)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Flu vaccination: generally safe after GBS; discuss with neurologist (6 weeks post-onset minimum; risk-benefit individualized)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "COVID-19 vaccination: discuss risk-benefit with neurologist; most experts recommend vaccination after recovery",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Transverse myelitis",
      "features": "Sensory level, upper motor neuron signs (hyperreflexia, Babinski), bladder involvement early, MRI spinal cord lesion",
      "tests": "MRI spine (cord signal change); LP (pleocytosis more common); NCS/EMG (normal peripheral nerves)"
    },
    {
      "diagnosis": "Myasthenia gravis",
      "features": "Fatigable weakness, ptosis, diplopia, intact reflexes, fluctuating symptoms, no sensory involvement",
      "tests": "AChR antibodies, repetitive nerve stimulation (decremental), edrophonium test"
    },
    {
      "diagnosis": "Botulism",
      "features": "Descending paralysis (cranial nerves first), pupil involvement, GI prodrome, toxin exposure",
      "tests": "Stool/serum botulinum toxin assay; NCS (incremental response at high-rate repetitive stimulation)"
    },
    {
      "diagnosis": "Tick paralysis",
      "features": "Ascending paralysis similar to GBS; tick found on exam; rapid recovery after tick removal",
      "tests": "Physical exam (search for tick, especially scalp); NCS may show reduced CMAPs; CSF normal"
    },
    {
      "diagnosis": "Spinal cord compression",
      "features": "Back pain, sensory level, upper motor neuron signs below level, bladder dysfunction",
      "tests": "MRI spine (compressive lesion)"
    },
    {
      "diagnosis": "Acute intermittent porphyria",
      "features": "Abdominal pain, psychiatric symptoms, autonomic dysfunction, motor predominant neuropathy, dark urine",
      "tests": "Urine ALA and PBG (elevated during attack)"
    },
    {
      "diagnosis": "Poliomyelitis / West Nile virus",
      "features": "Asymmetric flaccid paralysis, fever, anterior horn cell pattern, CSF pleocytosis",
      "tests": "CSF (elevated WBC); viral PCR; MRI (anterior horn signal)"
    },
    {
      "diagnosis": "CIDP",
      "features": "Similar to GBS but progression >8 weeks, relapsing-remitting course, may respond to steroids",
      "tests": "NCS/EMG (demyelinating); temporal course >8 weeks; steroid response"
    },
    {
      "diagnosis": "Critical illness myopathy/neuropathy",
      "features": "ICU setting, prolonged ventilation, steroid/neuromuscular blocker exposure",
      "tests": "NCS/EMG; CK (elevated in myopathy); clinical context"
    },
    {
      "diagnosis": "Hypokalemia",
      "features": "Diffuse weakness, cardiac arrhythmia, normal reflexes or hyporeflexia",
      "tests": "Serum potassium; ECG; rapid improvement with replacement"
    },
    {
      "diagnosis": "Conversion disorder (FND)",
      "features": "Non-physiologic weakness pattern, Hoover sign, give-way weakness, psychiatric history",
      "tests": "Normal NCS/EMG; normal LP; clinical exam"
    },
    {
      "diagnosis": "Diphtheria",
      "features": "Pharyngeal membrane, palatal weakness, sensorimotor neuropathy weeks after infection",
      "tests": "Throat culture; clinical history"
    },
    {
      "diagnosis": "HIV-associated neuropathy",
      "features": "Progressive, often sensory predominant; CSF pleocytosis distinguishes from GBS",
      "tests": "HIV testing; CSF (WBC >50 suggests HIV, not classic GBS)"
    }
  ],
  "evidence": [
    {
      "recommendation": "IVIG 0.4 g/kg/day x 5 days",
      "evidenceLevel": "Class I, Level A",
      "source": "[Dutch GBS Study Group, NEJM 1992](https://pubmed.ncbi.nlm.nih.gov/1552913/); [Cochrane Review, Hughes 2014](https://pubmed.ncbi.nlm.nih.gov/25238327/)"
    },
    {
      "recommendation": "PLEX (5 exchanges) equivalent to IVIG",
      "evidenceLevel": "Class I, Level A",
      "source": "[French Cooperative Group, Ann Neurol 1987](https://pubmed.ncbi.nlm.nih.gov/2893583/); North American GBS Study"
    },
    {
      "recommendation": "IVIG + PLEX combination NOT superior to either alone",
      "evidenceLevel": "Class I, Level A",
      "source": "[PE/Sandoglobulin GBS Trial Group, Lancet 1997](https://pubmed.ncbi.nlm.nih.gov/9014908/)"
    },
    {
      "recommendation": "Corticosteroids alone NOT effective for GBS",
      "evidenceLevel": "Class I, Level A",
      "source": "[Cochrane Review, Hughes 2016](https://pubmed.ncbi.nlm.nih.gov/27775812/)"
    },
    {
      "recommendation": "IVIG + IV methylprednisolone may shorten recovery (weak evidence)",
      "evidenceLevel": "Class IIb, Level B",
      "source": "[Dutch GBS Study Group, Lancet 2004](https://pubmed.ncbi.nlm.nih.gov/14738791/)"
    },
    {
      "recommendation": "Bedside FVC and NIF for respiratory monitoring",
      "evidenceLevel": "Class I, Level B",
      "source": "[Lawn et al. Arch Neurol 2001](https://pubmed.ncbi.nlm.nih.gov/11405803/)"
    },
    {
      "recommendation": "20/30/40 rule for intubation",
      "evidenceLevel": "Class IIa, Level C",
      "source": "Expert consensus; [Wijdicks & Borel, Neurology 1998](https://pubmed.ncbi.nlm.nih.gov/9443451/)"
    },
    {
      "recommendation": "Avoid succinylcholine in GBS",
      "evidenceLevel": "Class III (Harm)",
      "source": "Risk of hyperkalemia from denervated muscle"
    },
    {
      "recommendation": "Neuropathic pain management (gabapentin, carbamazepine)",
      "evidenceLevel": "Class IIa, Level B",
      "source": "[Pandey et al. Anesth Analg 2002](https://pubmed.ncbi.nlm.nih.gov/12456446/); Cochrane Review"
    },
    {
      "recommendation": "Early rehabilitation improves outcomes",
      "evidenceLevel": "Class I, Level B",
      "source": "[Khan & Amatya, Eur J Phys Rehabil Med 2012](https://pubmed.ncbi.nlm.nih.gov/22820829/); GBS-CIDP Foundation recommendations"
    },
    {
      "recommendation": "DVT prophylaxis",
      "evidenceLevel": "Class I, Level C",
      "source": "Standard of care for immobilized patients"
    },
    {
      "recommendation": "Anti-ganglioside antibodies (diagnostic, not required)",
      "evidenceLevel": "Class IIa, Level B",
      "source": "Diagnostic sensitivity varies by subtype"
    },
    {
      "recommendation": "Brighton criteria for GBS diagnosis",
      "evidenceLevel": "Class IIa, Level C",
      "source": "[Brighton Collaboration, Vaccine 2011](https://pubmed.ncbi.nlm.nih.gov/20600491/)"
    },
    {
      "recommendation": "IgA level before IVIG",
      "evidenceLevel": "Class I, Level C",
      "source": "Standard safety measure"
    },
    {
      "recommendation": "LP with albuminocytologic dissociation",
      "evidenceLevel": "Class I, Level B",
      "source": "Classic diagnostic finding; may be normal in first week"
    }
  ],
  "monitoring": [
    {
      "item": "Forced Vital Capacity (FVC)",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "STAT",
      "frequency": "q4-6h in hospital (q2h if declining); q1-2h in ICU if concerning trend",
      "action": "If FVC <20 mL/kg or declining >30% from baseline → elective intubation; transfer to ICU"
    },
    {
      "item": "Negative Inspiratory Force (NIF/MIP)",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "STAT",
      "frequency": "q4-6h with FVC",
      "action": "If NIF weaker than -30 cmH2O → prepare for intubation"
    },
    {
      "item": "Peak Cough Flow",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "-",
      "ICU": "ROUTINE",
      "frequency": "q4-6h with FVC",
      "action": "Airway clearance interventions; suction; assisted cough"
    },
    {
      "item": "Single Breath Count",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "-",
      "ICU": "STAT",
      "frequency": "q4h (bedside screening)",
      "action": "If <10-15 → declining respiratory function, correlate with FVC"
    },
    {
      "item": "Oxygen saturation (SpO2)",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "-",
      "ICU": "STAT",
      "frequency": "Continuous in ICU; q4h on floor",
      "action": "Late finding — do NOT rely on SpO2 alone; FVC is more sensitive"
    },
    {
      "item": "Blood pressure",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "-",
      "ICU": "STAT",
      "frequency": "q4h on floor; continuous in ICU",
      "action": "If BP lability (swings >20 mmHg): short-acting agents only; avoid long-acting antihypertensives; telemetry"
    },
    {
      "item": "Heart rate and rhythm (telemetry)",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "-",
      "ICU": "STAT",
      "frequency": "Continuous x 48h minimum; longer if autonomic symptoms",
      "action": "Bradycardia: atropine ready; Tachycardia: volume, pain control; AV block: consider temporary pacing"
    },
    {
      "item": "Neurologic exam (strength, reflexes)",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "STAT",
      "frequency": "q4-8h; Hughes GBS disability scale daily",
      "action": "Worsening → repeat FVC/NIF; consider additional immunotherapy"
    },
    {
      "item": "Swallowing function",
      "ED": "URGENT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "STAT",
      "frequency": "Daily assessment; formal SLP if bulbar symptoms",
      "action": "NPO if unsafe; NG or PEG for nutrition"
    },
    {
      "item": "Pain assessment (NRS 0-10)",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "STAT",
      "frequency": "q4h with vitals",
      "action": "Adjust pain regimen"
    },
    {
      "item": "Bowel function",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "ROUTINE",
      "frequency": "Daily",
      "action": "Bowel program; avoid ileus (autonomic dysfunction)"
    },
    {
      "item": "Bladder function",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "ROUTINE",
      "frequency": "I/O monitoring; post-void residual if needed",
      "action": "Bladder scan; intermittent catheterization if retention"
    },
    {
      "item": "Renal function (BUN, Cr)",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "-",
      "ICU": "ROUTINE",
      "frequency": "Daily during IVIG; q48h otherwise",
      "action": "Hold IVIG if rising Cr; hydration"
    },
    {
      "item": "Sodium",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "-",
      "ICU": "ROUTINE",
      "frequency": "Daily",
      "action": "SIADH workup if <130; fluid restriction"
    }
  ],
  "disposition": [
    {
      "disposition": "Discharge home",
      "criteria": "Mild GBS (ambulatory without assistance, Hughes 0-2), stable respiratory function (FVC >60% predicted), adequate pain control on oral medications, safe swallowing, reliable outpatient follow-up, family/caregiver support"
    },
    {
      "disposition": "Admit to floor (monitored bed preferred)",
      "criteria": "Any GBS requiring treatment; unable to ambulate independently; FVC 20-30 mL/kg with no downward trend; mild bulbar symptoms; needs IVIG or PLEX"
    },
    {
      "disposition": "Admit to ICU",
      "criteria": "FVC <20 mL/kg or declining rapidly; NIF weaker than -30 cmH2O; intubated or imminent intubation; autonomic instability (BP lability, arrhythmia); severe bulbar weakness with aspiration risk; unable to protect airway"
    },
    {
      "disposition": "Transfer to higher level of care",
      "criteria": "Need for PLEX not available on-site; need for ICU with neurology expertise; rapidly progressive course"
    },
    {
      "disposition": "Inpatient rehabilitation",
      "criteria": "Significant motor deficits (unable to walk independently; Hughes 3-4); able to participate in 3h/day therapy; medically stable"
    },
    {
      "disposition": "Skilled nursing facility",
      "criteria": "Unable to tolerate intensive rehabilitation; requires ongoing nursing care; severe deconditioning"
    }
  ]
}